Literature DB >> 3753485

Characterization of structural unit of phospholamban by amino acid sequencing and electrophoretic analysis.

J Fujii, M Kadoma, M Tada, H Toda, F Sakiyama.   

Abstract

The partial amino acid sequence of phospholamban from canine cardiac sarcoplasmic reticulum was determined by sequence analysis of the peptides obtained from the protein cleaved by cyanogen bromide and with TPCK-trypsin. The sequence determined initiated with N alpha-acetylated methionine followed by 44 amino acid residues intervening two unidentified residues. This polypeptide would represent a structural unit (protomer) of phospholamban. Analysis of temperature-dependent conversion of phospholamban from 26 kDa to lower molecular weight form (6 kDa) suggested that phospholamban holoprotein is composed of five identical protomers.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3753485     DOI： 10.1016/s0006-291x(86)80387-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  11 in total

1.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban.

Authors:  H Verboomen; F Wuytack; H De Smedt; B Himpens; R Casteels
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

3.  Phospholamban phosphorylation increases the passive calcium leak from cardiac sarcoplasmic reticulum.

Authors:  Roozbeh Aschar-Sobbi; Teresa L Emmett; Gary J Kargacin; Margaret E Kargacin
Journal:  Pflugers Arch       Date:  2012-07-07       Impact factor: 3.657

4.  Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban.

Authors:  J Fujii; A Ueno; K Kitano; S Tanaka; M Kadoma; M Tada
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Probing the helical tilt and dynamic properties of membrane-bound phospholamban in magnetically aligned bicelles using electron paramagnetic resonance spectroscopy.

Authors:  Harishchandra Ghimire; Shadi Abu-Baker; Indra D Sahu; Andy Zhou; Daniel J Mayo; Ryan T Lee; Gary A Lorigan
Journal:  Biochim Biophys Acta       Date:  2011-12-04

6.  Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study.

Authors:  Shadi Abu-Baker; Gary A Lorigan
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

7.  Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.

Authors:  W A Jackson; J Colyer
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

8.  Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy.

Authors:  Shadi Abu-Baker; Jun-Xia Lu; Shidong Chu; Clarke C Brinn; Christopher A Makaroff; Gary A Lorigan
Journal:  Biochemistry       Date:  2007-10-02       Impact factor: 3.162

9.  Investigating structural changes in the lipid bilayer upon insertion of the transmembrane domain of the membrane-bound protein phospholamban utilizing 31P and 2H solid-state NMR spectroscopy.

Authors:  Paresh C Dave; Elvis K Tiburu; Krishnan Damodaran; Gary A Lorigan
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

10.  (15)N Solid-state NMR spectroscopic studies on phospholamban at its phosphorylated form at ser-16 in aligned phospholipid bilayers.

Authors:  Shidong Chu; Shadi Abu-Baker; Junxia Lu; Gary A Lorigan
Journal:  Biochim Biophys Acta       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.